These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 36094777)

  • 1. Evaluation of Topical Antifungals Using a New Predictive Animal Model for Efficacy against Severe Tinea Unguium: A Comparison of Efinaconazole and Luliconazole.
    Masumoto A; Sugiura K; Matsuda Y; Tachibana H; Tatsumi Y
    Mycopathologia; 2022 Dec; 187(5-6):481-489. PubMed ID: 36094777
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel method for predicting the efficacy of topical drugs on onychomycosis: A comparison of efinaconazole and luliconazole.
    Masumoto A; Takagi M; Sugiura K; Matsuda Y; Nakamura S; Tatsumi Y
    J Mycol Med; 2022 Aug; 32(3):101259. PubMed ID: 35255449
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characteristics and Efficacy of Two Topical Therapeutic Agents for Onychomycosis.
    Kawai M
    Med Mycol J; 2019; 60(3):71-74. PubMed ID: 31474693
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The low keratin affinity of efinaconazole contributes to its nail penetration and fungicidal activity in topical onychomycosis treatment.
    Sugiura K; Sugimoto N; Hosaka S; Katafuchi-Nagashima M; Arakawa Y; Tatsumi Y; Jo Siu W; Pillai R
    Antimicrob Agents Chemother; 2014 Jul; 58(7):3837-42. PubMed ID: 24752277
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparative study between two antifungal agents, Luliconazole and Efinaconazole, of their preventive effects in a Trichophyton-infected guinea pig onychomycosis model.
    Nakamura A; Hirakawa S; Nagai H; Inagaki K
    Med Mycol; 2021 Mar; 59(3):289-295. PubMed ID: 33539539
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy Coefficients Determined Using Nail Permeability and Antifungal Activity in Keratin-Containing Media Are Useful for Predicting Clinical Efficacies of Topical Drugs for Onychomycosis.
    Matsuda Y; Sugiura K; Hashimoto T; Ueda A; Konno Y; Tatsumi Y
    PLoS One; 2016; 11(7):e0159661. PubMed ID: 27441843
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Topical efinaconazole: A sequential combination therapy with oral terbinafine for refractory tinea unguium.
    Noguchi H; Kubo M; Kashiwada-Nakamura K; Makino K; Aoi J; Fukushima S
    J Dermatol; 2021 Sep; 48(9):1401-1404. PubMed ID: 34028842
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Topical and device-based treatments for fungal infections of the toenails.
    Foley K; Gupta AK; Versteeg S; Mays R; Villanueva E; John D
    Cochrane Database Syst Rev; 2020 Jan; 1(1):CD012093. PubMed ID: 31978269
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preparation and
    Lee BC; Pangeni R; Na J; Koo KT; Park JW
    Drug Deliv; 2019 Dec; 26(1):1167-1177. PubMed ID: 31738083
    [TBL] [Abstract][Full Text] [Related]  

  • 10. How effective is efinaconazole in the management of onychomycosis?
    Gupta AK; Cernea M
    Expert Opin Pharmacother; 2016; 17(4):611-8. PubMed ID: 26809447
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efinaconazole topical solution (10%) for the treatment of onychomycosis in adult and pediatric patients.
    Vlahovic TC; Gupta AK
    Expert Rev Anti Infect Ther; 2022 Jan; 20(1):3-15. PubMed ID: 34106031
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Topical efinaconazole: A promising therapeutic medication for tinea unguium.
    Noguchi H; Matsumoto T; Hiruma M; Asao K; Hirose M; Fukushima S; Ihn H
    J Dermatol; 2018 Oct; 45(10):1225-1228. PubMed ID: 30035311
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transungual delivery of efinaconazole: its deposition in the nail of onychomycosis patients and in vitro fungicidal activity in human nails.
    Sakamoto M; Sugimoto N; Kawabata H; Yamakawa E; Kodera N; Pillai R; Tatsumi Y
    J Drugs Dermatol; 2014 Nov; 13(11):1388-92. PubMed ID: 25607707
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic efficacy of topically applied KP-103 against experimental tinea unguium in guinea pigs in comparison with amorolfine and terbinafine.
    Tatsumi Y; Yokoo M; Senda H; Kakehi K
    Antimicrob Agents Chemother; 2002 Dec; 46(12):3797-801. PubMed ID: 12435679
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efinaconazole Topical Solution, 10% Efficacy in Patients with Onychomycosis and Coexisting Tinea Pedis.
    Markinson B; Caldwell B
    J Am Podiatr Med Assoc; 2015 Sep; 105(5):407-11. PubMed ID: 26429609
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Update on Efinaconazole 10% Topical Solution for the Treatment of Onychomycosis.
    Gupta AK; Studholme C
    Skin Therapy Lett; 2016 Nov; 21(6):7-11. PubMed ID: 27825175
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tinea and Onychomycosis.
    Rosen T
    Semin Cutan Med Surg; 2016 Jun; 35(6 Suppl):S110-3. PubMed ID: 27537822
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Comparison of Characteristics of Two Topical Therapeutic Agents for Onychomycosis].
    Shimamura T; Miyamae A; Imai A; Hirayanagi K; Iwanaga T; Kubota N; Shibuya K
    Med Mycol J; 2016; 57(4):J141-J147. PubMed ID: 27904059
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efinaconazole 10% topical solution for the topical treatment of onychomycosis of the toenail.
    Lipner SR; Scher RK
    Expert Rev Clin Pharmacol; 2015; 8(6):719-31. PubMed ID: 26325488
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efinaconazole in Onychomycosis.
    Gupta AK; Talukder M
    Am J Clin Dermatol; 2022 Mar; 23(2):207-218. PubMed ID: 34902110
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.